VR Logo

Hikal Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

40 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids;

Incorporated: 1988

Chairman: Jai Hiremath

Managing Director: Jai Hiremath

Group: Kalyani

Listing: NSE: HIKAL, BSE: 524735

Headquarters: Mumbai, Maharashtra

Website: www.hikal.com

Key Facts

Market cap: R 1,488.86 Cr

Revenue (TTM): R 1,507.26 Cr

Earnings (TTM): R 84.43 Cr

Cash: R 31.74 Cr

Total Debt: R 660.92 Cr

Promoters' ownership: 68.77%

Liquidity: High

52 Week range: R 56.90 - 169.90

Face value: R2.00

Shares outstanding: 12,33,00,750

10 Years Aggregate:

  • CFO: 1,353.39 Cr
  • EBITDA: 1,891.98 Cr
  • Net Profit: 551.82 Cr

Stock Performance

Time Period Hikal S&P BSE Healthcare S&P BSE Small Cap
YTD5.6021.85-6.67
1 month-2.422.176.85
3 months35.4516.6828.11
1 Year-26.5530.34-7.32
3 Years-3.754.38-6.86
5 Years7.13-0.602.40
10 Years8.2311.023.30
As on 08-Jul-2020
Year Hikal S&P BSE Small Cap S&P BSE Healthcare
2019-26.92-6.85-3.55
20180.05-23.41-5.89
20179.4459.640.49
201627.161.77-12.88
201510.096.7615.06
201464.7669.2447.43
2013-9.27-11.2322.55